CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | Saint Sean President & CEO | Sale 10b5-1 | −5,641 | $20.08 | $113K | 398,429 |
| 2026-09-02 | Russell Steven Jon Chief Medical Officer | Sale | −4,221 | $19.11 | $81K | 169,628 |
| 2026-09-02 | Saint Sean President & CEO | Sale | −16,867 | $19.11 | $322K | 404,070 |
| 2026-09-02 | Feider Stephen Chief Financial Officer | Sale | −6,675 | $19.11 | $128K | 159,378 |
| 2026-09-02 | Mensinger Mike Chief Product Officer | Sale | −4,375 | $19.11 | $84K | 180,040 |
| 2026-09-02 | Hopman Mark Chief Commercial Officer | Sale | −5,327 | $19.11 | $102K | 124,027 |
| 2026-06-29 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +4,896 | $5.10 | $25K | 170,949 |
| 2026-06-29 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −4,896 | $17.03 | $83K | 166,053 |
| 2026-06-29 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −4,896 | 39,695 | ||
| 2026-06-29 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +4,896 | $5.10 | $25K | 170,827 |
| 2026-06-29 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −4,896 | $17.03 | $83K | 165,931 |
| 2026-06-29 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −4,896 | 39,817 | ||
| 2026-06-26 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +5,104 | $5.10 | $26K | 171,157 |
| 2026-06-26 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −5,104 | $17.05 | $87K | 166,053 |
| 2026-06-26 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,104 | 44,591 | ||
| 2026-06-26 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +4,982 | $5.10 | $25K | 171,035 |
| 2026-06-26 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −5,104 | $17.05 | $87K | 165,931 |
| 2026-06-26 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −4,982 | 44,713 | ||
| 2026-06-24 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −1,258 | $15.01 | $19K | 129,354 |
| 2026-06-24 | Jones Christy Director | Sale 10b5-1 | −1,406 | $15.00 | $21K | 25,994 |
Page 2 of 11 · 210 trades